Your browser doesn't support javascript.
loading
Efecto de Noni C sobre el daño hepático inducido por tetracloruro de carbono en ratas / Effect of Noni C on the carbon tetrachloride-induced hepatic damage in rats
Jiménez Martínez, María del Carmen; Maceira Cubiles, María Acelia; Martínez Martín, Sara M; Pérez de Alejo, José Luis; Montero González, Teresita.
  • Jiménez Martínez, María del Carmen; Hospital Militar Central Dr. Luis Díaz Soto. CU
  • Maceira Cubiles, María Acelia; Hospital Militar Central Dr. Luis Díaz Soto. CU
  • Martínez Martín, Sara M; Hospital Militar Central Dr. Luis Díaz Soto. CU
  • Pérez de Alejo, José Luis; Hospital Militar Central Dr. Luis Díaz Soto. CU
  • Montero González, Teresita; Hospital Militar Central Dr. Luis Díaz Soto. CU
Rev. cuba. plantas med ; 18(1): 92-99, ene.-mar. 2013.
Article in Spanish | LILACS | ID: lil-667494
RESUMEN

Introducción:

las enfermedades hepáticas son un serio problema de salud. El estudio de agentes de origen natural que disminuyan el daño hepático inducido por sustancias químicas ha despertado un interés especial.

Objetivo:

evaluar el efecto del Noni C sobre el daño hepático inducido por tetracloruro de carbono, en modelo experimental desarrollado en ratas Wistar machos.

Métodos:

se realizó estudio experimental y se usó como control positivo el tetracloruro de carbono a dosis de 0,3 mL/kg de peso, intraperitoneal, durante 3 días; y como control negativo solución salina. Se utilizaron 4 dosis (85, 130, 170 y 215 mg/kg de peso) de Noni C durante 6 días, postratamiento con tetracloruro de carbono. Se determinaron niveles de transaminasa glutámico pirúvica y glutámico oxalacética; también lesión hepática como tumefacción celular, hepatitis reactiva, esteatosis y necrosis.

Resultados:

se obtuvo reducción significativa de las transaminasas glutámico pirúvica y glutámico oxalacética a las dosis de 85 y 170 mg/kg de Noni C, y ausencia de necrosis y esteatosis en los grupos tratados con las dosis de 170 y 215 mg/kg de peso.

Conclusiones:

en los grupos tratados con Noni C disminuyó el daño hepático inducido por el tetracloruro de carbono
ABSTRACT

Introduction:

liver diseases are a serious health problem. The study of natural agents that can reduce the chemical substance-induced hepatic damage has aroused a particular interest.

Objective:

to evaluate the effect of Noni C on the carbon tetrachloride-induced hepatic damage in an experimental model developed in male Wistar rats.

Methods:

An experimental study was conducted in which the positive control was carbon tetrachloride at a dose of 0.3 mL/kg of weight, intraperitoneally administered for 3 days, and the negative control was saline solution. Four doses of Noni C(85, 130, 170 and 215 mg/kg of weight) were administered for 6 days, after treatment with the carbon tetrachloride. glutamic piruvic and glutamic oxaloacetic transaminase levels were determined, as well as hepatic lesions such as cell tumors, reactive hepatitis, steatosis and necrosis.

Results:

glutamic piruvic and glutamic oxaloacetic transaminases levels significantly decreased at doses of 85 and 170 mg/kg of Noni C, and no necrosis or steatosis was observed in the groups treated with 170 and 215 mg/kg doses.

Conclusions:

the carbon tetrachloride-induced hepatic damage diminished in the groups treated with Noni C
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Carbon Tetrachloride / Morinda / Chemical and Drug Induced Liver Injury Language: Spanish Journal: Rev. cuba. plantas med Journal subject: Public Health / Complementary Therapies Year: 2013 Type: Article Affiliation country: Cuba Institution/Affiliation country: Hospital Militar Central Dr/CU

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Carbon Tetrachloride / Morinda / Chemical and Drug Induced Liver Injury Language: Spanish Journal: Rev. cuba. plantas med Journal subject: Public Health / Complementary Therapies Year: 2013 Type: Article Affiliation country: Cuba Institution/Affiliation country: Hospital Militar Central Dr/CU